Xuan Xie1,2, Jiahao Zhou3, Qingbin Wu3

  • 1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

Carcinogenesis
|January 15, 2026
PubMed
概括

这项研究确定了用于预测结直肠癌 (CRC) 存活率的新型血蛋白签名. PD-L1被强调为CRC预后的潜在生物标志物和治疗标.